Saviah Technologies, Inc.
Update：2026/08/06
Industries
Main Industry
Information Technology
Main Product/Service
1. Ostevoke Bone Graft
2. Porcine Collagen Type I
3. Rat Tail Collagen Type I
4. μCapsul™ Controlled-Release Polymer
5. Formulation Service
6. Ubi-chan
2. Porcine Collagen Type I
3. Rat Tail Collagen Type I
4. μCapsul™ Controlled-Release Polymer
5. Formulation Service
6. Ubi-chan
Founded Year
2021
Unified Business No.
90876283
Status
Active
Number of Employees
0
Total Paid-in
Capital
93,904,630 (NT$)
Location of Company
Taiwan
, Hsinchu City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Saviah Technologies provides 5G core (Saviah 5GC) network software-as-a-service to system vendors/ SI/ service provider to fulfill the critical needs of private 5G network. Saviah 5GC complies 3GPP R15/R16 standard and has been integrated into end-to-end solutions by domestic/international vendors like Pegatron, Askey, AlphaNetwork, Supermicro etc, fostering cost-effective solutions for global private 5G network market. The solutions can be deployed on premises or in cloud-native manner. And the performance of Saviah 5GC has been proved by several vertical applications like smart factory, smart healthcare and entertainment arena. The advantages of Saviah 5GC: 1. Cost-effective 2. Support open interfaces and collaborate with multi-vendors 3. Fit RAN/O-RAN 4. Support agile customization
